FDA approves first new Alzheimer’s drug in nearly 20 years
Marketwatch reports that the Food and Drug Administration's accelerated approval of Biogen’s drug to treat Alzheimer’s disease is a significant step in the fight against the debilitating illness that destroys memory and other mental functions. But the experts say there's still a long way to go. Biogen Inc.’s drug, called aducanumab but branded with the name Aduhelm, is the first treatment for Alzheimer’s to be approved since 2003, and is […]
